Angiodynamics to report fiscal 2025 third quarter financial results on april 2, 2025 and host virtual cardiovascular investor event

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the third quarter of fiscal year 2025 before the market open on wednesday, april 2, 2025, followed by a virtual cardiovascular investor event, offering a deeper dive into th.
ANGO Ratings Summary
ANGO Quant Ranking